The condition affects 50 million people with significant negative effects on an individual's physical and psychological health. Epilepsy costs the UK NHS over £1.5 billion each year.

Up to 75% of people with epilepsy could be seizure-free. However, two major factors prevent appropriate diagnosis and treatment. First, limited access to expert neurologists, and second the difficulties of diagnosing specific forms of epilepsy based on witness accounts alone.

This new digital service will allow patients and carers to share video remotely, quickly and securely with their care team which can greatly improve diagnostic accuracy and selection of the right therapy.

The addition of AI-powered automated analysis and triage of consented videos will be a transformative addition to the diagnostic segment, complementing and supporting current growth in the epilepsy therapies.

Epilepsy Awareness

Numbers in Brief

Epilepsy affects 600,000 people in the UK and 50 million people globally. Epilepsy is commonest in children and over-60s, and confers a heavy burden.

  • 50mGlobal sufferers
  • 8% Increase annually
  • 42% Deaths preventable
  • 30b Cost per year

This service could contribute to improved seizure control in 75% of epilepsy-sufferers, leading to reduced injuries, better physical and mental health, and reduced epilepsy deaths.

It will also help reduce the economic burden of epilepsy on healthcare providers and wider society by reducing unscheduled hospital attendances, inappropriate epilepsy prescriptions and costs of investigation, as well as helping people return to work.

Project Partners

  • vCreate

    vCreate is a UK-based digital services provider, with a 20-year track record of application development and delivery in the health and commercial sectors.

  • NHS Greater Glasgow and Clyde

    NHS GGC is the largest health board in the UK. It delivers effective and high quality health services to over 1.2 million people and employs around 38,000 staff.

Current Status - July 2024
Clinical Evaluation

Contact Details

To find out more, please contact us.